Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $38.18 USD
Change Today -0.23 / -0.60%
Volume 1.0M
As of 2:50 PM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

hologic inc (HOLX) Snapshot

Open
$38.05
Previous Close
$38.41
Day High
$38.41
Day Low
$37.78
52 Week High
06/26/15 - $38.55
52 Week Low
10/15/14 - $22.70
Market Cap
10.7B
Average Volume 10 Days
2.1M
EPS TTM
$0.54
Shares Outstanding
281.0M
EX-Date
--
P/E TM
71.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for HOLOGIC INC (HOLX)

hologic inc (HOLX) Related Businessweek News

No Related Businessweek News Found

hologic inc (HOLX) Details

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment provides Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, instrumentation, Invader chemistry platform, ThinPrep system, fetal fibronectin tests, Procleix family of assays, and virology and infectious disease products. The Breast Health segment provides breast imaging and related products and accessories, including digital and film-based mammography systems; computer-aided detection (CAD) for mammography; invasive breast biopsy devices; breast biopsy site markers; breast biopsy guidance systems; and breast brachytherapy products. This segment also offers Dimensions platform, a mammography gantry for 2D and 3D image acquisition and display; C-View that provides a 2D image; breast MRI coils and workstations; and photoconductor coatings. The GYN Surgical segment provides NovaSure system to treat women suffering from abnormal uterine bleeding; and MyoSure system for the hysteroscopic removal of fibroids. The Skeletal Health segment offers discovery and horizon X-ray bone densitometers that assess the bone density of fracture sites; and mini C-arm imaging systems to perform minimally invasive surgical procedures on a patient’s extremities, such as the hand, wrist, knee, foot, and ankle. Hologic, Inc. sells its products through direct sales and service forces, and a network of independent distributors and sales representatives. The company has a strategic alliance with Quest Diagnostics Incorporated. Hologic, Inc. was founded in 1985 and is headquartered in Bedford, Massachusetts.

5,351 Employees
Last Reported Date: 11/20/14
Founded in 1985

hologic inc (HOLX) Top Compensated Officers

Chairman of the Board, Chief Executive Office...
Total Annual Compensation: $792.3K
Chief Financial Officer
Total Annual Compensation: $147.1K
Chief Operating Officer
Total Annual Compensation: $199.0K
Executive Officer
Total Annual Compensation: $600.0K
Compensation as of Fiscal Year 2014.

hologic inc (HOLX) Key Developments

Hologic, Inc. Announces Private Offering of $1.0 Billion Aggregate Principal Amount of Senior Notes Due 2022

Hologic Inc. announced that it has launched, subject to market and other conditions, a private offering of $1.0 billion aggregate principal amount of its senior notes due 2022. Hologic intends to use the proceeds of the offering, plus available cash, to redeem its outstanding 6.25% senior notes due 2020 in the aggregate principal amount of $1.0 billion. The 2022 notes will not be registered under the Securities Act of 1933, as amended, or any state securities laws. Unless so registered, the securities may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. The 2022 notes are being offered only to qualified institutional buyers in reliance on Rule 144A under the Securities Act, and outside the United States in accordance with Regulation S under the Securities Act. Hologic will redeem the 2020 notes on August 1, 2015, subject to the completion of the offering and the receipt of its proceeds, for an aggregate redemption price of $1.03125 billion. In addition, Hologic will make a final interest payment in the amount of $31.25 million for interest accrued to August 1, 2015, to holders of record of the 2020 notes as of July 15, 2015.

Hologic, Inc. Announces Board Changes

Hologic Inc. announced that David LaVance has resigned as chairman of the company's board of directors, and notified the board that he will not stand for re-election at the 2016 annual meeting of stockholders. Steve MacMillan, company's president and chief executive officer, has been appointed chairman of the board. In addition, current director Elaine Ullian, retired president and chief executive officer of the Boston Medical Center, has been appointed lead independent director. Ullian has been a member of the company's board since 2007.

Hologic Seeks Acquisitions

Hologic Inc. (NasdaqGS:HOLX) is looking for acquisitions. Steve Macmillan, President and Chief Executive Officer of Hologic, Inc. said " So that is a classic example, if we could drop in another product either developed internally or it's a classic example if we could find a tuck-in product that fits our needs. That would be an area that I think would be a good use of potential acquisition, fits the strategy completely, but we got to find the right product, so we're looking now.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HOLX:US $38.18 USD -0.23

HOLX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DENTSPLY International Inc $51.52 USD +0.13
Edwards Lifesciences Corp $144.85 USD +2.40
MEDNAX Inc $74.84 USD +0.034
Mettler-Toledo International Inc $345.29 USD -1.17
Cooper Cos Inc/The $176.38 USD -0.21
View Industry Companies
 

Industry Analysis

HOLX

Industry Average

Valuation HOLX Industry Range
Price/Earnings 93.8x
Price/Sales 4.2x
Price/Book 5.0x
Price/Cash Flow 19.8x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HOLOGIC INC, please visit www.hologic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.